Abstract
A phase I clinical trial of cis-platinum (II) diamminedichloride (PDD) was initiated at Roswell Park Memorial Institute in August 1971. The pre-clinical studies of this inorganic compound indicated a striking activity in several animal tumor models including Dunning ascitic leukemia and Walker 256 carcinosarcoma, Sarcoma 180, and DMBA induced mammary tumors in female rats [3, 4, 5]. The spectrum of toxic effects in these and other pre-clinical studies suggested the possibility of some specificity of activity in human cancers. The genitourinary tract in rats, dogs, and monkeys showed evidence of severe tissue injury at less than lethal doses [1, 2]. Acute tubular necrosis with azotemia and marked atrophy of the prostate gland were seen in monkeys and dogs and testicular atrophy was seen in monkeys. We, therefore, sought patients with advanced genitourinary cancer for inclusion in this study.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Heyman, I. A., Thompson, G. R., Schiappi, A. H., Rosenkrantz, H., Fleishman, R. W., et al.: Report MRI 6002–71–19, Contract NIH–70–2055, Dept. of HEW, PHS, NIH, NCI, Laboratory of Toxicology, 1971.
Kociba, R. J., Sleight, S. D.: Acute toxicologic and pathologic effects of cis-diamminedidlloroplatinum (NSC-119 875) in the male rat. Cancer Chemother. Rep. (Part 1 ) 55, 1 (1971).
Kociba, R. J., Sleight, S. D., Rosenberg, B.: Inhibition of dunning ascitic leukemia and Walker 256 carcinosarcoma with cis-diamminedidlloroplatinum (NSC-119 875). Cancer Chemother. Rep. (Part 1 ) 54, 5 (1970).
Rosenberg, B., Van Camp, L.: The successful regression of large solid sarcoma 180 tumors by platinum compounds. Cancer Res. 30, 1977 (1970).
Speer, R. J., Lapis, S., Ridgeway, H., Meyers, T. D., Hill, J. M.: Cis-platinumdiamminedichloride (PDD) in combination therapy of leukemia L-1210. Wadley Med. Bull. 1, 103 (1971)
Welsch, C. W.: Effects of cis-platinumdiamminedichloride(II) on growth of 7,12-dimethylbenzanthracene (DMBA) induced mammary tumors in female rats. Abstract 100, Pharmacologist 12, 2 (1970).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Wallace, H.J., Higby, D.J. (1974). Phase I Evaluation of cis-Platinum (II) Diamminedichloride (PDD) and a Combination of PDD Plus Adriamycin. In: Connors, T.A., Roberts, J.J. (eds) Platinum Coordination Complexes in Cancer Chemotherapy. Recent Results in Cancer Research, vol 48. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-49306-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-49306-5_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-49308-9
Online ISBN: 978-3-642-49306-5
eBook Packages: Springer Book Archive